ADAM 10 expression in primary uveal melanoma as prognostic factor for risk of metastasis
- 1 November 2016
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 212 (11) , 980-987
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- ADAM protease inhibitors reduce melanogenesis by regulating PMEL17 processing in human melanocytesJournal of Dermatological Science, 2015
- Clinical Presentation, Pathological Features and Natural Course of Metastatic Uveal Melanoma, an Orphan and Commonly Fatal DiseaseOncology, 2014
- Congenital uveal malignant melanomaJournal of American Association for Pediatric Ophthalmology and Strabismus, 2014
- Immunolocalization of lubricin in the rat periodontal ligament during experimental tooth movementActa Histochemica, 2012
- Uveal melanomaCancer Treatment Reviews, 2012
- ADAM10 Is Upregulated in Melanoma Metastasis Compared with Primary MelanomaJournal of Investigative Dermatology, 2010
- Role of ADAMs in Cancer Formation and ProgressionClinical Cancer Research, 2009
- A critical appraisal of the prognostic and predictive factors for uveal malignant melanomaHistopathology, 2004
- The ADAM gene family: surface proteins with adhesion and protease activityTrends in Genetics, 2000
- Modifications of Callender's Classification of Uveal Melanoma at the Armed Forces Institute of PathologyAmerican Journal of Ophthalmology, 1983